The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Bodycad sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Bodycad is a medical equipment company that designs products and technologies for orthopaedic implant surgery. The company offers 3D models of the bone, customized plate solutions, screws, and other surgical equipment. The company’s major brands are BC OnCall and BC Fine Osteotomy. Using its proprietary technology (Personalized Restoration Evaluation Process) Preplink, the company conducts patient scans, validates designs, and accomplishes the restoration process. Bodycad sells its products through its distributors in the US, Canada, and the UK. Bodycad is headquartered in Rue du Haut-Bord, Quebec, Canada.
The key metrics of Bodycad related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Bodycad is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Bodycad.
For a detailed understanding of the performance of Bodycad, buy the report here.